For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM2629Aa&default-theme=true
RNS Number : 2629A Applied Nutrition PLC 13 April 2026
Applied Nutrition plc
Director/PDMR Dealing
Applied Nutrition plc (the "Company"), a leading sports nutrition, health and
wellness brand, announces the following transaction in the Company's shares.
This announcement is made in accordance with Article 19(1) of the EU Market
Abuse Regulation as incorporated into UK law through the European Union
(Withdrawal) Act 2018.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Marnie Millard
2 Reason for the notification
a) Position/status PDMR / Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Applied Nutrition plc
b) LEI 213800KCP1IDX51ZHE47
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.0002 each
Identification code GB00BPVDXX64
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Price Volume
£2.249112 13,257
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 2026-04-13
f) Place of the transaction XOFF
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSFMFIDEMSELL
Copyright 2019 Regulatory News Service, all rights reserved